Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-24 @ 11:19 PM
NCT ID:
NCT01246856
Eligibility Criteria:
Inclusion Criteria:
* Female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
* (Neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (TAC) completed one year before inclusion
Exclusion Criteria:
* Evidence of breast cancer recurrence or metastatic disease
* Evidence of heart disease at the time of breast cancer diagnosis
* Evidence of renal failure at the time of cardiac evaluation
* Pregnant or lactating
* Participation in a research protocol with ionizing radiation within one year before inclusion.
* Evidence of diabetes mellitus or Parkinson's disease
* Evidence of an MIBG-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01246856
Study Brief:
Protocol Section:
NCT01246856